| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0012400 | Exon-Exon | chr7:122120906-122377122 | chr7:122480852-122737068 | 250 nt | 0.2960 |
| hsa_CADPS2_0012500 | Exon-Exon | chr7:122130135-122221344 | chr7:122490081-122581290 | 629 nt | 0.4229 |
| hsa_CADPS2_0015300 | Exon-Exon | chr7:122194604-122221344 | chr7:122554550-122581290 | 252 nt | 0.4444 |
| hsa_CADPS2_0015400 | Exon-Exon | chr7:122194604-122261771 | chr7:122554550-122621717 | 608 nt | 0.4194 |
| hsa_CADPS2_0016200 | Exon-Exon | chr7:122221233-122269382 | chr7:122581179-122629328 | 549 nt | 0.4390 |
| hsa_CADPS2_0017200 | Exon-Exon | chr7:122255235-122269382 | chr7:122615181-122629328 | 437 nt | 0.4188 |
| hsa_CADPS2_0019400 | Exon-Exon | chr7:122377009-122377122 | chr7:122736955-122737068 | 114 nt | 0.4386 |
| hsa_CADPS2_0019500 | Intron-Exon-Intron | chr7:122377009-122429184 | chr7:122736955-122789130 | 250 nt | 0.3720 |
| hsa_chr7_0100700 | Intergenic-Intergenic | chr7:122495420-122497411 | chr7:122855366-122857357 | 1992 nt | 0.3800 |
| hsa_CADPS2_0012400 | Exon-Exon | chr7:122120906-122377122 | chr7:122480852-122737068 | 250 nt | 0.2960 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].